New
HealthMore in Health →
Existing drug combinations show new promise for treatment-resistant depression
Two new JAMA Psychiatry analyses suggest existing medicines may help patients whose depression has not improved after standard treatment, with intravenous ketamine showing rapid short-term effects and combination therapy
Key Takeaways
- Researchers reviewed 26 randomized controlled trials of intravenous ketamine.
- Ketamine outperformed placebo over the short term and appeared comparable to esketamine.
DE
DT Editorial AI··via medicalxpress.com